Careers

Our companies are made up of insanely talented people driven to change the world — and many of them are hiring. If you have drive, expertise, and a taste for adventure, we wholeheartedly encourage your interest.

0

Companies Hiring
0

Open Roles

jobs

Explore

companies

Join talent network

Talent

My job alerts

Showing 88 companies

Abcellera is breaking the barriers of conventional antibody drug discovery to bring better medicines to patients, sooner. Abcellera’s engine integrates expert teams, technology, and facilities with the data science and automation needed to propel antibody-based medicines from target to clinic in nearly every therapeutic area with precision and speed. Abcellera provides innovative biotechs and leading pharmaceutical companies with a competitive advantage that empowers them to move quickly, reduce cost, and tackle the toughest problems in drug development.

Agility Robotics

33 jobs

Manufacturing

Mechanical or Industrial Engineering

201 - 1000 employees

We started with scientific breakthroughs and layered on top of that world-class engineering. We approach everything with a focus on function. Our humanoid robots were designed from day one to do useful work.

Alation is the first data catalog built for collaboration. With Alation, analysts are empowered to search, query, and collaborate on their data to achieve faster, more accurate insights. Alation automatically captures the rich context of enterprise data, including what the data describes, who has used it, and the fit between the data and different types of analysis. Alation’s catalog is generated and updated using machine learning and improved through human collaboration between analysts, stewards, experts, and business users. Alation is funded by Andreessen Horowitz, Bloomberg Beta, Costanoa Venture Capital, Data Collective, and General Catalyst Partners. Customers include eBay, MarketShare, and some of the world’s largest finance and retail firms.

Alchemab Therapeutics

4 jobs

Biotechnology

51 - 200 employees

Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of hard-to-treat disease in a unique and transformative approach to drug discovery and development. Alchemab takes an unbiased and function-first approach using three complementary processes and cutting-edge technologies to identify naturally protective antibodies. Alchemab’s engine is enabled through collaborations with patient representative groups and biobanks around the world with whom we partner to further our understanding of disease.

Alta Resource Technologies

Alta Resource Technologies is a climate technology company focused on next-generation mining for critical minerals, aiming to optimize resource extraction while minimizing environmental impact. Their innovative approach positions them as a leader in the sustainable mining sector, catering to the growing demand for critical minerals essential for modern technology and renewable energy solutions.

Asimov

7 jobs

51 - 200 employees

Asimov builds tools to program living cells. By integrating mammalian synthetic biology, computer-aided design, and machine learning, our multi-disciplinary team is advancing the design and manufacture of biologics and gene therapies.

Atomwise is a preclinical pharma company revolutionizing how drugs are discovered with AI. Atomwise has strengthened its drug discovery and development expertise by expanding its Board of Directors and creating a Scientific Advisory Board (SAB). These appointments signal a critical milestone for Atomwise as the company focuses on its own internal pipeline. We invented the use of deep learning for structure-based drug discovery, today developing a pipeline of small-molecule drug candidates advancing into preclinical studies. Our AtomNet® technology has been used to unlock more undruggable targets than any other AI drug discovery platform. We are tackling over 600 unique disease targets with more than 250 partners around the world, including leading pharmaceutical, agrochemical, and emerging biotechnology companies. Atomwise has raised over $174 million from leading venture capital firms to advance our mission to make better medicines, faster.

Axelar

1 jobs

Blockchain and Crypto

Computer & Network Security

Security

Software

11 - 50 employees

Axelar is a cross-chain communication tool developing interoperability software to connect blockchain ecosystems, applications, and users. Axelar Network consists of a protocol suite, tools, and APIs, designed to break down the barriers to cross-chain communication. Axelar enables developers to build on the best platform for their needs whileleveraging the Axelar stack to unlock cross-chain composability and liquidity.

Professional Services

51 - 200 employees

Brimstone is pioneering a decarbonized cement solution that addresses one of the most significant climate challenges. Founded by Cody Finke and Hugo Leandri, the company has developed a breakthrough process that produces ordinary portland cement and supplementary cementitious materials with a significantly reduced carbon footprint. Their technology utilizes carbon-free calcium silicate rock instead of traditional limestone, ensuring that the product remains chemically and physically identical to conventional cement while being cost-competitive at scale. With a focus on transforming the cement industry from a climate problem to a climate hero, Brimstone is poised to make a substantial impact on global CO2 emissions, which account for 7.5% of total emissions from cement production.

Capella Space

40 jobs

Defense & Space

Government and Military

201 - 1000 employees

Capella Space is an American space tech company with data and satellite solutions for government and commercial use. A pioneer in the Earth observation industry, Capella is the first U.S. company with a constellation of Synthetic Aperture Radar (SAR) satellites, delivering high quality, high resolution SAR imagery. Capella provides easy access to frequent and timely information affecting dozens of industries worldwide, including defense and intelligence, supply chain, insurance, maritime, and others. Its market-leading SAR satellites are matched with unparalleled data infrastructure to quickly deliver reliable global insights that sharpen our understanding of the changing world – improving decisions about commerce, conservation, and security on Earth. Headquartered in San Francisco, California, with additional locations in Denver, Colorado, and Washington, D.C., Capella’s satellites are operated, designed, and manufactured in the USA. Learn more at www.capellaspace.com.

Carbon Health is a human-centered, tech-enabled healthcare company. Our mission is to remove traditional boundaries in healthcare and make high-quality, personalized care accessible to everyone.

CH4 Global

Agriculture and Farming

51 - 200 employees

Our mission: Urgently impact climate change, at scale, by harnessing the power of Asparagopsis seaweed to reduce methane from cows. This is because we believe: * Climate change is real. Humanity is running out of time to act. Agriculture/methane is a significant contributor to climate change. * Nature can inspire and technology can deliver a meaningful difference. Seaweed is an unrealized resource that nature has provided to reduce methane in cows. * We are realists about convincing the world to do things differently. We want to make change as easy as possible. * We are certain that we can make a difference by bringing individuals, communities, governments, and industry together. The company’s bold vision is for zero methane agriculture by bending the climate curve. Because cutting methane will significantly slow short-term global warming. CH4’s urgent initiative is to cut methane emissions from livestock by making available to the world sustainable, globally-scaled products containing a unique seaweed. This special seaweed, Asparagopsis, has over 10 years of research behind it and has shown effects of 60-90% reduction in methane emissions from both dairy and beef cattle and sheep. As we, at CH4 Global, work to make Asparagopsis products real, we are committed to doing this in a way that makes it easy for farmers to adopt and that will benefit communities where we aqua-farm. We are collaborating with local communities to ensure that all can benefit from our work. Our management team and advisory board come with significant research, development, marketing, large-scale production, distribution, and investment experience in major global companies. We are based in the USA, New Zealand, and Australia.